This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: None, Subject name: Pharmacology
[{'content': 'All of the following are approved for the treatment of relapsing-remmitting multiple sclerosis (RRMS) subtype, except- \nSelect and explain. \nA. IFN - beta - la, B. IFN - beta - lb, C. Glatiramer, D. Mycophenolate', 'role': 'user'}, {'content': "Answer: D \nExplanation: Ans. is 'd' i.e. Mycophenololate Treatment of RRMS o Treatment of RRMS is divided into:? (i) In acute attack: Coicosteroids are given (ii) Prophylaxis of acute attack (relapse) during remission: Disease modifying agents for MS are used to reduce the biological activity. Treatment is staed by IFN-131a or IFN-131b or Glatiramer or fingalimod. If there is poor response or intolerance to these drugs, Natalizumab is staed. Treatment of progressive subtype of MS o Treatment is staed with l FN-fil a or IFN-$lb. o If there is poor response or intolerance, one of the following should be considered: (i) Mitoxantrone; (ii) Azathio? prine; (iii) Methotrexate (iv) IV immunoglobulin; (v) Pulse cyclophosphamide; (vi) Pulse methylprednisolone.", 'role': 'assistant'}]